Compare INTG & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INTG | CCEL |
|---|---|---|
| Founded | 1965 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building operators | Managed Health Care |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.3M | 32.7M |
| IPO Year | 1995 | 2022 |
| Metric | INTG | CCEL |
|---|---|---|
| Price | $35.90 | $3.15 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.9K | ★ 7.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.72% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.46 | N/A |
| Revenue | ★ $74,753,000.00 | $25,384,279.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $82.54 | ★ N/A |
| Revenue Growth | 4.43 | ★ 9.76 |
| 52 Week Low | $10.37 | $3.10 |
| 52 Week High | $42.50 | $6.99 |
| Indicator | INTG | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 62.63 | 29.97 |
| Support Level | $25.16 | $3.11 |
| Resistance Level | $37.75 | $3.57 |
| Average True Range (ATR) | 1.32 | 0.04 |
| MACD | 0.78 | -0.01 |
| Stochastic Oscillator | 75.71 | 0.00 |
The Intergroup Corp is a company operating in the real estate sector. It was formed to buy, develop, operate, rehabilitate, and dispose of real property of various types and descriptions, as well as to engage in other related business and investment activities. The company operates through three segments: Hotel, Real Estate, and Investment Transactions. The Hotel Operations segment, which generates the majority of the revenue, covers the operation of the Hilton hotel and garage. The Real Estate Operations segment involves the management of multifamily rental properties, while the Investment Transactions segment includes investments of cash in marketable securities and other assets.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.